Who owns ENLIVEN THERAPEUTICS INC?
- Ticker: ELVN
- CUSIP Number: 29337e102
Tip: Access positions for across all investors
Analyze quarterly positions in Enliven Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enliven Therapeutics stock
Who bought or sold ENLIVEN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 9.0M | $125M | 0% | Dec 2023 |
|
| 5AM Venture Management | 5.2M | $71M | 0% | Dec 2023 |
|
| VR Adviser | 3.0M | $41M | 0% | Dec 2023 |
|
| Commodore Capital | 2.9M | $40M | 0% | Dec 2023 |
|
| Citadel Advisors | 2.4M | $33M | 2% | Dec 2023 |
|
| Fairmount Funds Management | 2.1M | $30M | 0% | Dec 2023 |
|
| RA Capital Management | 2.1M | $29M | 0% | Dec 2023 |
|
| Vanguard Group | 1.2M | $17M | 7% | Dec 2023 |
|
| Boxer Capital | 646k | $8.9M | 0% | Dec 2023 |
|
| Henderson Group | 409k | $5.7M | 48% | Dec 2023 |
|
| Logos Global Management | 307k | $4.2M | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 158k | $2.2M | 1% | Dec 2023 |
|
| Bank of New York Mellon | 80k | $1.1M | -1% | Dec 2023 |
|
| BML Capital Management | 50k | $692k | 0% | Dec 2023 |
|
| Barclays | 42k | $583k | 209% | Dec 2023 |
|
| Rhumbline Advisers | 37k | $517k | 9% | Dec 2023 |
|
| Swiss National Bank | 37k | $505k | -10% | Dec 2023 |
|
| Bank of America Corporation | 31k | $425k | 33% | Dec 2023 |
|
| Exchange Traded Concepts | 25k | $434k | 184% | Mar 2024 |
|
| Jpmorgan Chase & Co | 24k | $332k | -9% | Dec 2023 |
|
| Goldman Sachs Group | 23k | $314k | 28% | Dec 2023 |
|
| Credit Suisse | 22k | $303k | -4% | Dec 2023 |
|
| Legal & General Group | 20k | $272k | 0% | Dec 2023 |
|
| State of Wisconsin Investment Board | 18k | $253k | -4% | Dec 2023 |
|
| Jane Street | 16k | $217k | 100% | Dec 2023 |
|
| Alliancebernstein | 15k | $207k | 4% | Dec 2023 |
|
| SG Americas Securities | 14k | $187k | 18% | Dec 2023 |
|
| MetLife Investment Advisors | 12k | $171k | 0% | Dec 2023 |
|
| Mirae Asset Global Investments | 12k | $170k | 9% | Dec 2023 |
|
| American International | 12k | $161k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 11k | $147k | -2% | Dec 2023 |
|
| New York State Common Retirement Fund | 9.4k | $130k | -1% | Dec 2023 |
|
| Royal Bank of Canada | 8.0k | $109k | 70% | Dec 2023 |
|
| Citigroup | 7.4k | $104k | 121% | Dec 2023 |
|
| Wells Fargo & Company | 7.2k | $99k | 25% | Dec 2023 |
|
| China Universal Asset Management | 4.8k | $66k | 100% | Dec 2023 |
|
| AJOVista | 2.0k | $28k | 100% | Dec 2023 |
|
| Amalgamated Bank | 2.0k | $28k | -10% | Dec 2023 |
|
| Advisor Group Holdings | 2.0k | $28k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 1.9k | $27k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.3k | $18k | 0% | Dec 2023 |
|
| GAMMA Investing | 53.00 | $931.999700 | 43% | Mar 2024 |
|
| Baystate Wealth Management | 50.00 | $692.000000 | 0% | Dec 2023 |
|
| Russell Investments | 12.00 | $165.999600 | 100% | Dec 2023 |
|
| NISA Investment Advisors | 9.00 | $125.000100 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 6.00 | $82.999800 | 100% | Dec 2023 |
|
| Pnc Financial Services | 5.00 | $69.000000 | 100% | Dec 2023 |
|
| CWM | 4.00 | $0 | 100% | Mar 2024 |
|
| Covestor | 1.00 | $0 | 0% | Dec 2023 |
|
Who sold out of Enliven Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cormorant Asset Management | Sep 2023 | 1.2M | $17M |
| Frazier Life Sciences Management | Sep 2023 | 1.1M | $14M |
| AQR Capital Management | Sep 2023 | 13k | $177k |
| Allspring Global Investments Holdings | Sep 2023 | 566.00 | $7.7k |
| UBS Group | Sep 2023 | 105.00 | $1.4k |